SCHEMBL9218779

SCHEMBL9218779

O=P(O)(O)C(CS(=O)(=O)O)N=C1CCCCN1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FKBP5 Q13451 1/20 0.31
CRBN Q96SW2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9083443 0.75 FKBP5 (0.34) FKBP5CRBN
SCHEMBL8713203 0.71
SCHEMBL8713208 0.71
SCHEMBL9081580 0.68 FDPS (0.39) FKBP5CRBN
SCHEMBL8949672 0.61 GABRP (0.34) FKBP5CRBN
SCHEMBL9084352 0.60 FKBP5 (0.32) FKBP5CRBN
Sulfuric Acid SCHEMBL30278662 0.59 CRBN (0.76) FKBP5CRBN
SCHEMBL2916419 0.58
SCHEMBL3265053 0.58
SCHEMBL12129960 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0642518-A1 PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS (US) 1995-03-15 EP disclosed
WO-1993024495-A1 PHOSPHONOSULFONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1993-12-09 WO disclosed